Back

A clinically integrated, frameless human Neuropixels workflow

Layard Horsfall, H.; Toma, A. K.; Watkins, L.; Akram, H.; Marcus, H. J.; Stewart, A.; Chatburn, J.; Vanhoestenberghe, A.; Coughlin, B. F.; Paulk, A. C.; Cash, S. S.; Welkenhuysen, M.; Dutta, B.; Schaefer, A. T.; Kollo, M.; Muirhead, W.

2026-05-18 neurology
10.64898/2026.05.07.26351853 medRxiv
Show abstract

High-density electrophysiological recording using Neuropixels probes enables single-unit resolution of human neural activity. However, integrating these systems into clinical environments remains challenging. Reported human recordings have been limited to a few centres in the United States utilising variable regulatory, sterilisation and operative techniques. Here, we present human Neuropixels recordings under a nationally managed ethical and regulatory framework in the United Kingdom. We provide a reproducible roadmap to overcome regulatory and equipment constraints. Guided by the IDEAL Stage 2a (Development) framework, we established a frameless intraoperative workflow utilising manufacturer-sterilised probes and a commercially available, clinical-grade setup for Neuropixels insertion including micromanipulator and endoscope holder. We prospectively evaluated this workflow across six participants (mean age 62.5 years) undergoing elective ventriculoperitoneal shunt surgery. Iterative failure-mitigation cycles successfully resolved key technical barriers, including neuronavigation interference and hardware instability. Assessed across three predefined endpoints (clinical safety, procedural timing, and neural data yield), the workflow achieved zero research-related adverse events and maintained a strict 30-minute procedural extension. Progressive technical refinements increased single-unit yield from 25 units during early development to 146 manually curated units. This approach provides a scalable, clinically integrated workflow to safely perform high-density electrophysiology in routine neurosurgical environments.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Journal of Neural Engineering
197 papers in training set
Top 0.2%
14.7%
2
PLOS ONE
4510 papers in training set
Top 17%
10.3%
3
Scientific Reports
3102 papers in training set
Top 9%
8.6%
4
Journal of Neuroscience Methods
106 papers in training set
Top 0.1%
7.3%
5
Annals of Clinical and Translational Neurology
29 papers in training set
Top 0.2%
4.1%
6
IEEE Transactions on Biomedical Engineering
38 papers in training set
Top 0.2%
3.7%
7
Med
38 papers in training set
Top 0.2%
2.1%
50% of probability mass above
8
Nature Communications
4913 papers in training set
Top 50%
1.8%
9
Brain Communications
147 papers in training set
Top 2%
1.7%
10
Brain
154 papers in training set
Top 3%
1.7%
11
Nature Medicine
117 papers in training set
Top 2%
1.7%
12
Stroke: Vascular and Interventional Neurology
13 papers in training set
Top 0.3%
1.7%
13
Neurocritical Care
11 papers in training set
Top 0.2%
1.7%
14
Epilepsia
49 papers in training set
Top 0.5%
1.7%
15
Nature Biomedical Engineering
42 papers in training set
Top 1%
1.5%
16
eLife
5422 papers in training set
Top 46%
1.4%
17
Advanced Science
249 papers in training set
Top 13%
1.4%
18
Imaging Neuroscience
242 papers in training set
Top 3%
1.3%
19
npj Digital Medicine
97 papers in training set
Top 3%
1.0%
20
Frontiers in Integrative Neuroscience
12 papers in training set
Top 0.2%
0.9%
21
Neurophotonics
37 papers in training set
Top 0.5%
0.9%
22
Kidney360
22 papers in training set
Top 0.5%
0.9%
23
BMJ Health & Care Informatics
13 papers in training set
Top 0.8%
0.8%
24
Clinical Chemistry
22 papers in training set
Top 0.7%
0.8%
25
Critical Care Explorations
15 papers in training set
Top 0.4%
0.8%
26
Communications Biology
886 papers in training set
Top 23%
0.8%
27
PLOS Digital Health
91 papers in training set
Top 3%
0.8%
28
Brain Stimulation
112 papers in training set
Top 1%
0.8%
29
Journal of Visualized Experiments
30 papers in training set
Top 0.8%
0.7%
30
Frontiers in Digital Health
20 papers in training set
Top 2%
0.7%